HCW BIOLOGICS INC (HCWB) Stock Income Statement
NASDAQ:HCWB - Nasdaq - US40423R2040 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 1.45M | 2.57M | 2.84M | 6.72M | 0.00 | |||
| Cost Of Goods | 1.10M | 1.61M | 2.28M | 4.14M | N/A | |||
| Gross Profit | 354.70K | 959.40K | 560.40K | 2.59M | N/A | |||
| Operating Expenses | 23.74M | 29.86M | 26.72M | 17.66M | 13.37M | |||
| Research and Development | N/A | 6.29M | 7.68M | 9.34M | 8.17M | |||
| Selling, General, and Administrative Expenses | 19.08M | 23.00M | 18.00M | 7.99M | 4.98M | |||
| Operating Income | -23.02M | -28.47M | -26.00M | -15.08M | -13.37M | |||
| Interest Income/Expense | N/A | -631.10K | -283.00K | -130.00K | -60.00K | |||
| Other Income/Expense | 80.00K | 90.00K | 1.01M | 300.00K | N/A | |||
| Non Recurring Items | N/A | -530.00K | N/A | N/A | 570.00K | |||
| Income Before Taxes | -24.47M | -30.00M | -25.00M | -14.90M | -12.86M | |||
| Income Tax | N/A | 0.00 | N/A | N/A | N/A | |||
| Net Income | -24.47M | -30.00M | -25.00M | -14.90M | -12.86M | |||
| EBITDA | -21.66M | -27.29M | -24.86M | -14.36M | -12.83M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -25.15 | -30.93 | -27.83 | -16.63 | -14.37 | |||
| Non GAAP EPS | N/A | N/A | -28.00 | -16.80 | N/A | |||
| Statistics | ||||||||
| Gross Profit Margin | 24.46% | 37.38% | 19.72% | 38.54% | N/A | |||
| Profit Margin | -1687.47% | -1168.77% | -879.72% | -221.73% | N/A | |||
| Operating Profit Margin | -1587.48% | -1109.16% | -914.91% | -224.40% | N/A | |||
All data in USD